IP Library Granted Patent US 12,616,849
Granted Patent B2
US 12,616,849 · App. 18/951,274 · Granted May 5, 2026

Sunglass lens and sunglass optics for ocular photo-bio-stimulation

Inventors: Ronald Blum (Atlanta, GA); Jack Loeb (Fisher Island, FL); Anita Broach (Christiansburg, VA)
Assignee: NEURORAYS, LLC
A61N5/0622A61N2005/0648A61N2005/0663A61N2005/0667
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,616,849
App. No.
18/951,274
Filed
Nov 18, 2024
Granted
May 5, 2026
Kind
B2
Art Unit
3792
USPC
607/45
Abstract

A lens or optic, including a sunglass lens or sunglass optic, providing ocular photo-bio-stimulation therapy.

Claims (18)

1 . A sunglass lens or sunglass optic, wherein the sunglass lens or sunglass optic provides light transmission of 40% or more of ocular photo-bio-stimulation light measured within a light wavelength range of 450 nm-510 nm to an eye of a wearer of the sunglass lens or sunglass optic, wherein a light transmission curve spectra of the sunglass lens or sunglass optic when superimposed on or over a light absorption curve spectra of melanopsin and rhodopsin covers 50% or more of the melanopsin and rhodopsin absorption curve spectra, wherein a visible light transmission (VLT) of the sunglass lens or sunglass optic is 30% or less, wherein the sunglass lens or sunglass optic is designed to transmit an amount of red light, yellow light, and green light, sufficient to pass a regulatory traffic signal test or standard for color transmission of red light, yellow light, and green light, and wherein a visible light transmission peak of the sunglass lens or sunglass optic does not exceed 40% within a light wavelength range of 600 nm-750 nm.

2 . The sunglass lens or sunglass optic of claim 1 , wherein the sunglass lens or sunglass optic is supported or housed by at least one of: eyewear, fit over eyewear, disposable eyewear, a helmet, augmented reality eyewear, virtual reality eyewear, mixed reality eyewear, modified reality eyewear, a contact lens(es), an intraocular lens(es), a corneal implant, or sunglasses.

3 . The sunglass lens or sunglass optic of claim 1 , wherein the sunglass lens or sunglass optic transmits light having an intensity of 350 lux or greater.

4 . The sunglass lens or sunglass optic of claim 1 , wherein the ocular photo-bio-stimulation light includes the light wavelength range of 450 nm-510 nm, and wherein the ocular photo-bio-stimulation light including the light wavelength range of 450 nm-510 nm stimulates a production of dopamine in the eye of the wearer.

5 . The sunglass lens or sunglass optic of claim 1 , wherein the ocular photo-bio-stimulation light includes the light wavelength range of 450 nm-510 nm, and wherein the ocular photo-bio-stimulation light including the light wavelength rage of 450 nm-510 nm stimulates a production of dopamine or serotonin in a brain of the wearer.

6 . The sunglass lens or sunglass optic of claim 1 , wherein the sunglass lens or sunglass optic comprises a surface cast layer that filters light.

7 . The sunglass lens or sunglass optic of claim 1 , wherein the sunglass lens or sunglass optic comprises a lens matrix or optics matrix that: filters or blocks ultraviolet light, is imbibed with a dye or light absorber, or combinations thereof.

8 . The sunglass lens or sunglass optic of claim 1 , wherein the sunglass lens or sunglass optic comprises one or more of: an interference filter, an absorption filter, a light absorber, dye, a neutral density filter, a bandpass filter, a notch filter, or a selective blue light filter.

9 . The sunglass lens or sunglass optic of claim 1 , wherein the sunglass lens or sunglass optic comprises an optical power, including plano optical power.

10 . The sunglass lens or sunglass optic of claim 1 , wherein a filtered tint of the sunglass lens or sunglass optic is fixed or constant.

11 . The sunglass lens or sunglass optic of claim 1 , wherein the sunglass lens or sunglass optic allows for light transmission of 400 lux or more within the light wavelength range of 450 nm-510 nm when worn in sunlight throughout a same day from morning daylight until early sunset of the same day.

12 . The sunglass lens or sunglass optic of claim 1 , wherein the sunglass lens or sunglass optic transmits light through the sunglass lens or sunglass optic within the range of 450 nm-510 nm having a light intensity of 350 lux or greater.

13 . The sunglass lens or sunglass optic of claim 1 , wherein the light transmission of 40% or more ocular photo-bio-stimulation light within the range of 450 nm-510 nm stimulates production of dopamine in the eye of the wearer or a brain of the wearer.

14 . The sunglass lens or sunglass optic of claim 1 , wherein the sunglass lens or sunglass optic comprises an optical power.

15 . The sunglass lens or sunglass optic of claim 1 , wherein the sunglass lens or sunglass optic is classified as a category 2 sunglass lens or sunglass optic.

16 . The sunglass lens or sunglass optic of claim 1 , wherein the sunglass lens or sunglass optic is classified as a category 3 sunglass lens or sunglass optic.

17 . The sunglass lens or sunglass optic of claim 1 , wherein light transmitted through the sunglass lens or sunglass optic has a light intensity of 350 lux or greater after transmission through the sunglass lens or sunglass optic.

18 . The sunglass lens or sunglass optic of claim 1 , wherein the sunglass lens or sunglass optic comprises plano optical power.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2024
From: BLUM, RONALD; BROACH, ANITA; LOEB, JACK
To: NEURORAYS, LLC
Reel/Frame 069320/0535 →
Continuity (30)
Continuation 18928126 · Oct 27, 2024
Continuation 18914202 · Oct 13, 2024
Continuation 18827786 · Sep 8, 2024
Continuation 18827782 · Sep 8, 2024
Provisional Application 63697560 · Sep 22, 2024
Provisional Application 63684509 · Aug 19, 2024
Provisional Application 63676855 · Jul 29, 2024
Provisional Application 63674219 · Jul 22, 2024
Provisional Application 63673746 · Jul 21, 2024
Provisional Application 63671237 · Jul 14, 2024
Provisional Application 63648098 · May 15, 2024
Provisional Application 63639892 · Apr 29, 2024
Provisional Application 63569005 · Mar 22, 2024
Provisional Application 63561266 · Mar 4, 2024
Provisional Application 63553693 · Feb 15, 2024
Provisional Application 63550852 · Feb 7, 2024
Provisional Application 63627703 · Jan 31, 2024
Provisional Application 63623253 · Jan 20, 2024
Provisional Application 63617363 · Jan 3, 2024
Provisional Application 63609306 · Dec 12, 2023
Provisional Application 63603258 · Nov 28, 2023
Provisional Application 63600139 · Nov 17, 2023
Provisional Application 63548204 · Nov 12, 2023
Provisional Application 63546848 · Nov 1, 2023
Provisional Application 63541243 · Sep 28, 2023
Provisional Application 63540090 · Sep 24, 2023
Provisional Application 63537021 · Sep 7, 2023
Provisional Application 63654566 · May 31, 2024
Provisional Application 63553226 · Feb 14, 2024
Related Publication 20250082961A1 · Mar 13, 2025
References Cited (122)
US 3826751A · Laliberte · 1974 [cited by applicant]
US 5083858A · Girerd · 1992 [cited by applicant]
US 5243460A · Kornberg · 1993 [cited by applicant]
US 5838419A · Holland · 1998 [cited by applicant]
US 5923398A · Goldman · 1999 [cited by applicant]
US 6350275B1 · Vreman et al. · 2002 [cited by applicant]
US 8469512B2 · Croft et al. · 2013 [cited by applicant]
US 8833937B2 · Shehadeh et al. · 2014 [cited by applicant]
US 8911082B2 · Ambler · 2014 [cited by applicant]
US 9028064B2 · Harris · 2015 [cited by applicant]
US 9138595B2 · Savage et al. · 2015 [cited by applicant]
US 9720228B2 · Harrison et al. · 2017 [cited by applicant]
US 9885884B2 · Drobe · 2018 [cited by applicant]
US 10073283B2 · Legerton · 2018 [cited by applicant]
US 10152906B2 · Gutierrez · 2018 [cited by applicant]
US 10219944B2 · Tedford et al. · 2019 [cited by applicant]
US 10386654B2 · Marshall et al. · 2019 [cited by applicant]
US 10444505B2 · Rousseau et al. · 2019 [cited by applicant]
US 10884246B2 · Blum et al. · 2021 [cited by applicant]
US 10884264B2 · Hones et al. · 2021 [cited by applicant]
US 10895735B1 · Feinbloom et al. · 2021 [cited by applicant]
US 10942373B2 · Barrau et al. · 2021 [cited by applicant]
US 11029540B2 · To et al. · 2021 [cited by applicant]
US 11048103B2 · Saylor et al. · 2021 [cited by applicant]
US 11061255B2 · Lau et al. · 2021 [cited by applicant]
US 11065468B2 · Barrau et al. · 2021 [cited by applicant]
US 11086145B2 · Flinders · 2021 [cited by applicant]
US 11099408B2 · McCabe et al. · 2021 [cited by applicant]
US 11131869B2 · Marshall et al. · 2021 [cited by applicant]
US 11420072B2 · He et al. · 2022 [cited by applicant]
US 11446514B2 · Bahmani et al. · 2022 [cited by applicant]
US 11701315B2 · Ishak et al. · 2023 [cited by applicant]
US 11711600B2 · Han et al. · 2023 [cited by applicant]
US 11774784B2 · Barrau et al. · 2023 [cited by applicant]
US 12055797B2 · Newman et al. · 2024 [cited by applicant]
US 12336937B2 · Tedford et al. · 2025 [cited by applicant]
US 20010056293A1 · Brainard · 2001 [cited by examiner]
US 20020198577A1 · Jaillet · 2002 [cited by applicant]
US 20100033830A1 · Yung · 2010 [cited by applicant]
US 20100103371A1 · Sarver et al. · 2010 [cited by applicant]
US 20100152849A1 · Degenaar et al. · 2010 [cited by applicant]
US 20120200823A1 · Bandhauer et al. · 2012 [cited by applicant]
US 20130211178A1 · Brigatti et al. · 2013 [cited by applicant]
US 20140176898A1 · Yi et al. · 2014 [cited by applicant]
US 20140247423A1 · Drobe · 2014 [cited by applicant]
US 20150088231A1 · Rubinfeld et al. · 2015 [cited by applicant]
US 20150142086A1 · Narita · 2015 [cited by applicant]
US 20150234207A1 · Koifman · 2015 [cited by applicant]
US 20160022225A1 · Palmer et al. · 2016 [cited by applicant]
US 20160026005A1 · Flinders · 2016 [cited by examiner]
US 20160067086A1 · Tedford et al. · 2016 [cited by applicant]
US 20160158572A1 · Nolan · 2016 [cited by examiner]
US 20160216537A1 · Drobe · 2016 [cited by applicant]
US 20160270656A1 · Samec et al. · 2016 [cited by applicant]
US 20160361437A1 · Lucas et al. · 2016 [cited by applicant]
US 20170299898A1 · Gallina et al. · 2017 [cited by applicant]
US 20180035101A1 · Osterhout · 2018 [cited by applicant]
US 20180185665A1 · Osterhout · 2018 [cited by examiner]
US 20190204624A1 · Barrau et al. · 2019 [cited by applicant]
US 20190212581A1 · Scherlen et al. · 2019 [cited by applicant]
US 20190258086A1 · Barrau et al. · 2019 [cited by applicant]
US 20210031051A1 · Kubota et al. · 2021 [cited by applicant]
US 20210132416A1 · Newman · 2021 [cited by examiner]
US 20210157172A1 · Barrau et al. · 2021 [cited by applicant]
US 20210382325A1 · Kubota et al. · 2021 [cited by applicant]
US 20220047887A1 · Honold et al. · 2022 [cited by applicant]
US 20220057651A1 · Segre et al. · 2022 [cited by applicant]
US 20220062634A1 · Masko et al. · 2022 [cited by applicant]
US 20220082860A1 · Guillot et al. · 2022 [cited by applicant]
US 20220111228A1 · Schoutens · 2022 [cited by applicant]
US 20220187628A1 · Valentine et al. · 2022 [cited by applicant]
US 20220233878A1 · Lee et al. · 2022 [cited by applicant]
US 20220252904A1 · Hones, Jr. et al. · 2022 [cited by applicant]
US 20220397774A1 · Barrau et al. · 2022 [cited by applicant]
US 20220413318A1 · Kubota et al. · 2022 [cited by applicant]
US 20230132952A1 · Youngblood et al. · 2023 [cited by applicant]
US 20230204982A1 · Boyles · 2023 [cited by examiner]
US 20230248937A1 · Blair et al. · 2023 [cited by applicant]
US 20230248993A1 · Bahmani et al. · 2023 [cited by applicant]
US 20230389161A1 · Coleman · 2023 [cited by applicant]
US 20240036357A1 · Schianchi et al. · 2024 [cited by applicant]
US 20240272454A1 · Zheleznyak et al. · 2024 [cited by applicant]
US 20240359031A1 · Marshall et al. · 2024 [cited by applicant]
US 20250082959A1 · Blum · 2025 [cited by examiner]
CN 103926710A · 2014 [cited by applicant]
CN 111938911A · 2020 [cited by applicant]
CN 212973238U · 2021 [cited by applicant]
EP 2772794A1 · 2014 [cited by applicant]
EP 3528036A1 · 2019 [cited by applicant]
EP 3528037A1 · 2019 [cited by applicant]
EP 4248925A2 · 2023 [cited by applicant]
EP 4296762A1 · 2023 [cited by applicant]
KR 20130006766U · 2013 [cited by applicant]
KR 102195466B1 · 2020 [cited by applicant]
KR 102436963B1 · 2022 [cited by applicant]
WO 2019109125A1 · 2019 [cited by applicant]
WO 2021105979A1 · 2021 [cited by applicant]
WO 2021116449A1 · 2021 [cited by applicant]
WO 2021252319A1 · 2021 [cited by applicant]
WO 2022094678A1 · 2022 [cited by applicant]
WO 2022187279A1 · 2022 [cited by applicant]
WO 2022219441A1 · 2022 [cited by applicant]
WO 2022258572A1 · 2022 [cited by applicant]
WO 2023186146A1 · 2023 [cited by applicant]
WO 2024094884A1 · 2024 [cited by applicant]
Application No. PCT/US2024/051175, International Search Report and Written Opinion dated Nov. 25, 2024. [cited by applicant]
Application No. PCT/US2024/053151, International Search Report and Written Opinion dated Jan. 2, 2025. [cited by applicant]
Application No. PCT/US2024/056407, International Search Report and Written Opinion dated Jan. 17, 2025. [cited by applicant]
Cardinal Intellectual Property Patent Search Report dated Nov. 4, 2024. [cited by applicant]
Chakraborty, R., et al.; Axial length reduction and choroidal thickening with short-term exposure to cyan light in human subjects; Ophthalmic Physiol Opt. 2024;00:1-19. https://doi.org/10.1111/opo.13390. [cited by applicant]
National Academies of Sciences, Engineering, and Medicine. 2024. Myopia: Causes, Prevention, and Treatment of an Increasingly Common Disease. Washington, DC: The National Academies Press. https://doi.org/10.17226/27734. [cited by applicant]
Visible Bandpass Filters; Optical Filter Shop; retrieved at https://opticalfiltershop.com/product-category/bandpass-filter/visible-bandpass-filters-390nm-to-750nm/?srsltid=AfmBOoq17fx_K3qa6-4IEMggf0z4wh0-EXqLU41U1dkCunE… [cited by applicant]
Application No. PCT/US2024/045750, International Search Report and Written Opinion dated Dec. 16, 2024. [cited by applicant]
Application No. PCT/US2024/045751, International Search Report and Written Opinion dated Dec. 16, 2024. [cited by applicant]
Application No. PCT/US2024/057354, International Search Report and Written Opinion dated Feb. 3, 2025. [cited by applicant]
Application No. PCT/US2025/012142, International Search Report and Written Opinion dated Mar. 5, 2025. [cited by applicant]
Capovilla, G.; Effectiveness of a particular blue lens on photoparoxysmal response in photosensitive epileptic patients; Ital J. Neurol Sci (1999) 20:161-166. [cited by applicant]
www.dopavision.com/product/, visited Sep. 11, 2024. [cited by applicant]
Akerman, D., Predicting the Onset of Myopia in Children, Review of Myopia Management, Jul. 15, 2024, https://reviewofmm.com/predicting-the-onset-of-myopia-in-children/, downloaded May 30, 2025. [cited by applicant]
Liu, Z., et al., The Effects of Repeated Low-Level Red-Light Therapy on the Structure and Vasculature of the Choroid and Retina in Children with Premyopia, Ophthalmol Ther 13:739-759 (2024), https://doi.org/10.1007/s401… [cited by applicant]
Lumivision & Wellbeing: Myproclear webpage; https://lumi-visionandwellbeing.co.uk/red-light-therapy-for-myopical-control/; downloaded May 19, 2025. [cited by applicant]
Mutti, D., et al., Predicting the onset of myopia in children by age, sex, ethnicity: Results from the CLEERE Study, Optom Vis Sci. Apr. 1, 2024;101(4):179-186, https://pmc.ncbi.nlm.nih.gov/articles/PMC11060695/, downlo… [cited by applicant]